Ann Dermatol.  2018 Feb;30(1):116-118. 10.5021/ad.2018.30.1.116.

A Case of Atrophoderma Vermiculatum Showing a Good Response to Topical Tretinoin

• Lee YC
• Son SJ
• Han TY
• Lee JH

• KMID: 2399774
• DOI: http://doi.org/10.5021/ad.2018.30.1.116

Abstract

No abstract available.

MeSH Terms

Tretinoin*
Tretinoin

Figure

• 

  Fig. 1 (A, B) Multiple, pitted oval in shape, skin-colored, 1~2 mm in diameter, and approximately 1 mm deep scars were evident on both cheeks (red arrow, yellow circle) and temples, and the chin and neck. (C, D) After treatment with 0.01% topical tretinoin for 12 months, pitlike erythematous atrophic scars improved cosmetic appearance (red arrow, yellow circle).

• 

  Fig. 2 Histopathological examination of an atrophic keratotic papule on the cheek revealed follicular hyperkeratosis; aberrant, atrophic pilosebaceous units, accompanied by sclerosis of the dermal collagen. Mild perifollicular fibrosis and chronic perifollicular inflammation were apparent (H&E; A: ×100, B: ×200).

Reference

1. Frosch PJ, Brumage MR, Schuster-Pavlovic C, Bersch A. Atrophoderma vermiculatum. Case reports and review. J Am Acad Dermatol. 1988; 18:538–542.

2. Luria RB, Conologue T. Atrophoderma vermiculatum: a case report and review of the literature on keratosis pilaris atrophicans. Cutis. 2009; 83:83–86.

3. Apalla Z, Karakatsanis G, Papageorgiou M, Kastoridou C, Chaidemenos G. A case of atrophoderma vermiculatum responding to systemic isotretinoin. J Dermatol Case Rep. 2009; 3:62–63.

4. Park J, Kim BJ, Kim MN, Lee CK. A pilot study of Q-switched 1064-nm Nd:YAG laser treatment in the keratosis pilaris. Ann Dermatol. 2011; 23:293–298.

5. Shim C, Song DH, Lee SH, Kim DS. Atrophoderma vermiculatum occuring in a patient with congenital heart disease. Korean J Dermatol. 1989; 27:222–226.